ArticleOncoTargets and therapy2026

Positive Feedback Between Oncogenic KRAS and HIF-1α Confers Drug Resistance in Colorectal Cancer [Retraction].

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.